Non-fasting triglyceride screening in volunteer blood donors: A pilot program
Caroline Abe1, Emily Decicco1, Stephen Eason2
1UT Southwestern Medical Center, Dallas, TX, United States (Abe, Decicco, Sayers, Makhnoon, Xing, Xing, Khera, Ahmad).
Journal of Clinical Lipidology
|January 24, 2025
Summary
Large-scale, non-fasting triglyceride screening at blood donation centers is feasible. This approach identifies individuals with hypertriglyceridemia, enabling early intervention for cardiovascular disease and pancreatitis prevention.
Area of Science:
- Public Health
- Cardiovascular Health
- Clinical Diagnostics
Background:
- Hypertriglyceridemia is a significant risk factor for cardiovascular disease and acute pancreatitis.
- Early detection of elevated triglyceride levels is crucial for timely intervention and prevention strategies.
Purpose of the Study:
- To assess the feasibility of large-scale, non-fasting triglyceride level screening at blood donation centers.
- To identify prevalence and predictors of hypertriglyceridemia in a blood donor population.
Main Methods:
- A pilot study involving 10,176 blood donors at Carter BloodCare North Texas.
- Measurement of non-fasting triglyceride levels and analysis of demographic and clinical predictors.
- A survey of donors with severe hypertriglyceridemia to assess intent to seek medical care.
Main Results:
- 39.2% of donors had moderate and 2.4% had severe hypertriglyceridemia.
- Predictors included age, male gender, blood pressure, body mass index, and ethnicity (Hispanic and Asian individuals showed increased odds).
- 69% of donors with severe hypertriglyceridemia expressed intent to seek medical care.
Conclusions:
- Blood donation centers are viable platforms for public health screening initiatives.
- Scaling low-cost, non-fasting triglyceride screening is feasible and offers opportunities for early disease detection and prevention.


